Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer

P. Forde, C. Murphy, C. O'Sullivan, D. Carney

Research output: Contribution to journalArticle


Introduction: Description of the cutaneous side effects of erlotinib. Materials: Report with images of a single case. Methods: Case report and review of the literature. Conclusion: Erlotinib is associated with significant cutaneous toxicity which should be recognised and managed appropriately.

Original languageEnglish (US)
Pages (from-to)283-284
Number of pages2
JournalIrish Journal of Medical Science
Issue number1
StatePublished - Mar 1 2011
Externally publishedYes



  • EGFR inhibitors
  • Erlotinib
  • Hair change
  • Non-small-cell lung cancer

ASJC Scopus subject areas

  • Medicine(all)

Cite this